Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension.

Tumor necrosis factor (TNF)-alpha is a key proinflammatory cytokine that is thought to be important in the development of pulmonary fibrosis, whereas its role in pulmonary emphysema has not been as thoroughly documented. In the present study, TNF-alpha was overexpressed in alveolar type II cells under the control of the human surfactant protein C promoter. In this report, we further characterized the pulmonary abnormalities and provided a physiological assessment of these mice. Histopathology of the lungs revealed chronic inflammation, severe alveolar air space enlargement and septal destruction, and bronchiolitis. However, pulmonary fibrosis was very limited and only seen in the subpleural, peribronchiolar, and perivascular regions. Physiological assessment showed an increase in lung volumes and a decrease in elastic recoil characteristic of emphysema; there was no evidence of restrictive lung disease characteristic of pulmonary fibrosis. In addition, the mice raised in ambient conditions in Denver developed pulmonary hypertension. Gelatinase activity was increased in the lavage fluid from these lungs. These results suggest that in these mice TNF-alpha contributed to the development of pulmonary emphysema through chronic lung inflammation and activation of the elastolytic enzymes but by itself was unable to produce significant pulmonary fibrosis.

[1]  P. Huang,et al.  The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia. , 1999, The Journal of clinical investigation.

[2]  B. Wuyam,et al.  Peripheral neuropathy in sleep apnea. A tissue marker of the severity of nocturnal desaturation. , 1999, American journal of respiratory and critical care medicine.

[3]  Y. Konttinen,et al.  Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[4]  F. Graham,et al.  Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts. , 1998, The American journal of pathology.

[5]  Z. Werb,et al.  Gelatinase B–deficient Mice Are Resistant to Experimental Bullous Pemphigoid , 1998, The Journal of experimental medicine.

[6]  C. Akdis,et al.  Role of interleukin 10 in specific immunotherapy. , 1998, The Journal of clinical investigation.

[7]  R. Wilmott,et al.  Generation of a transgenic mouse with lung-specific overexpression of the human interleukin-1 receptor antagonist protein. , 1998, American journal of respiratory cell and molecular biology.

[8]  D. Meldrum Tumor necrosis factor in the heart. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[9]  M. Kurosumi,et al.  Molecular pathogenesis of interstitial pneumonitis with TNF-alpha transgenic mice. , 1998, Cytokine.

[10]  M. Feldmann,et al.  Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: role of the p38 and p42/44 mitogen-activated protein kinases. , 1998, Journal of immunology.

[11]  R. Thrall,et al.  Role of tumor necrosis factor-alpha in the spontaneous development of pulmonary fibrosis in viable motheaten mutant mice. , 1997, The American journal of pathology.

[12]  J. Whitsett,et al.  Postnatal lung function and morphology in transgenic mice expressing transforming growth factor-alpha. , 1997, The American journal of pathology.

[13]  S. Shapiro,et al.  Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. , 1997, Science.

[14]  L. Borish,et al.  Increased expression of the interleukin-10 gene by alveolar macrophages in interstitial lung disease. , 1997, The American journal of physiology.

[15]  L. O’Driscoll,et al.  Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. , 1997, American journal of respiratory and critical care medicine.

[16]  J. Sheller,et al.  5-Lipoxygenase products are necessary for ovalbumin-induced airway responsiveness in mice. , 1997, The American journal of physiology.

[17]  C. O'connor,et al.  Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. , 1997, Thorax.

[18]  M. Suga,et al.  Altered accessory cell function of alveolar macrophages: a possible mechanism for induction of Th2 secretory profile in idiopathic pulmonary fibrosis. , 1997, The European respiratory journal.

[19]  D. Remick,et al.  TNF-alpha-mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis. , 1997, Journal of immunology.

[20]  M. Sułkowska,et al.  Tumor necrosis factor-alpha induces emphysema-like pulmonary tissue rebuilding. Changes in type II alveolar epithelial cells. , 1997, Polish journal of pathology : official journal of the Polish Society of Pathologists.

[21]  B. Beutler,et al.  The tumor necrosis factor ligand and receptor families. , 1996, The New England journal of medicine.

[22]  T. Mosmann,et al.  The expanding universe of T-cell subsets: Th1, Th2 and more. , 1996, Immunology today.

[23]  R. Rogers,et al.  Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients. , 1996, American journal of respiratory and critical care medicine.

[24]  P. Barnes,et al.  Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. , 1996, American journal of respiratory and critical care medicine.

[25]  J. Bousquet,et al.  Different cytokine patterns in bronchial biopsies in asthma and chronic bronchitis. , 1996, Respiratory medicine.

[26]  M. Cosio,et al.  Alveolar inflammation and its relation to emphysema in smokers. , 1995, American journal of respiratory and critical care medicine.

[27]  J. Whitsett,et al.  Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis. , 1995, The Journal of clinical investigation.

[28]  J. Mege,et al.  Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. , 1994, American journal of respiratory and critical care medicine.

[29]  C. O'connor,et al.  Matrix metalloproteases and lung disease. , 1994, Thorax.

[30]  C. Vesin,et al.  Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. , 1994, The European respiratory journal.

[31]  G. Grau,et al.  Expression and localization of tumor necrosis factor-alpha and its mRNA in idiopathic pulmonary fibrosis. , 1993, The American journal of pathology.

[32]  W. Thurlbeck,et al.  Collagen and elastin in human pulmonary emphysema. , 1993, The American review of respiratory disease.

[33]  H. Tanaka,et al.  Molecular cloning and expression of the mouse 105-kDa gelatinase cDNA. , 1993, Biochemical and Biophysical Research Communications - BBRC.

[34]  Y. Okada,et al.  Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema , 1992, Cell.

[35]  P. Familletti,et al.  Cloning and expression of murine IL-12. , 1992, Journal of immunology.

[36]  B. Meyrick,et al.  Morphologic changes in lungs of anesthetized sheep following intravenous infusion of recombinant tumor necrosis factor alpha. , 1991, The American review of respiratory disease.

[37]  S. Shapiro,et al.  Human 92- and 72-kilodalton type IV collagenases are elastases. , 1991, The Journal of biological chemistry.

[38]  Martine A. Collart,et al.  Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis , 1990, Nature.

[39]  P. Vassalli,et al.  Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis , 1989, The Journal of experimental medicine.

[40]  R. Stockley,et al.  Effects of plasma, tumour necrosis factor, endotoxin and dexamethasone on extracellular proteolysis by neutrophils from healthy subjects and patients with emphysema. , 1989, Clinical science.

[41]  J. J. Thompson,et al.  Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response. , 1989, The Journal of infectious diseases.

[42]  A. Mauviel,et al.  Tumor necrosis factor inhibits collagen and fibronectin synthesis in human dermal fibroblasts , 1988, FEBS letters.

[43]  A Janoff,et al.  Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis. , 1985, The American review of respiratory disease.

[44]  G. Maul,et al.  Nucleotide sequence of a cDNA clone for mouse proα 1(I) collagen protein , 1985 .

[45]  G. Maul,et al.  Nucleotide sequence of a cDNA clone for mouse pro alpha 1(I) collagen protein. , 1985, Gene.

[46]  G. Turino,et al.  Emphysema induced by intravenously administered endotoxin in an alpha 1-antitrypsin-deficient rat model. , 1984, The American review of respiratory disease.

[47]  G. Snider Emphysema associated with intravascular leukocyte sequestration. , 1981, The American review of respiratory disease.

[48]  J. Coalson,et al.  Emphysema associated with intravascular leukocyte sequestration. Comparison with papain-induced emphysema. , 1981, The American review of respiratory disease.

[49]  W. Thurlbeck,et al.  Postnatal growth of the mouse lung. , 1975, Journal of anatomy.

[50]  M. Dunnill Quantitative Methods in the Study of Pulmonary Pathology , 1962, Thorax.